← Scroll for more →
TG Therapeutics, Inc. (TGTX)
Pharmaceutical Preparations
Latest Price
$56.44
TTM P/E
20.60
Normalized P/E
265.44
TTM Div Yield
--
Fwd Div Yield
--
Book Value
3.95
P/B Ratio
14.30
Valuation metrics
adjust assumptions →EPS: $2.77
Book value / share: $4.17
Formula: √(22.5 × EPS × BVPS)
Graham Number
$16.13
71% downside
EPS: $2.77
Target P/E: 21×
Formula: EPS × P/E
P/E Fair Value
$58.17
+3% upside
Institutional Ownership
74.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 22.05M | $1.21B | 14.40% | -202.9K | 2026-06-30 |
| Vanguard Portfolio Management LLC | 7.96M | $437.0M | 5.20% | -310.7K | 2026-06-30 |
| State Street Corp | 7.79M | $427.0M | 5.09% | -863.3K | 2026-06-30 |
| Vanguard Capital Management LLC | 6.15M | $337.0M | 4.02% | -453.9K | 2026-06-30 |
| Geode Capital Management, LLC | 3.64M | $200.0M | 2.38% | +142.3K | 2026-06-30 |
| D. E. Shaw & Co., Inc. | 3.48M | $191.0M | 2.27% | +2.87M | 2026-06-30 |
| Soleus Capital Management, L.P. | 2.93M | $160.0M | 1.91% | -1.10M | 2026-06-30 |
| Price T Rowe Associates Inc | 2.77M | $152.0M | 1.81% | +2.13M | 2026-06-30 |
| Clearbridge Investments, LLC | 2.65M | $145.0M | 1.73% | -560.7K | 2026-06-30 |
| Congress Asset Management Co | 2.60M | $142.0M | 1.70% | +432.0K | 2026-06-30 |